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PENJANAAN DAN PENCIRIAN APTAMER  





 Demam denggi adalah wabak yang melanda wilayah tropika dan subtropika 
yang disebabkan oleh gigitan nyamuk. Menurut analisa yang dibuat oleh Organisasi 
Kesihatan Sedunia (WHO) baru-baru ini, adalah dianggarkan bahawa sebanyak 3.9 
bilion orang daripada 128 buah negara berisiko menghadapi jangkitan virus denggi. Ini 
menekankan keperluan ujian diagnostik denggi yang unggul dan sesuai, iaitu ujian 
yang mampu membezakan demam denggi daripada penyakit lain yang mempunyai 
manifestasi klinikal yang serupa, sangat sensitif, pantas dan dengan kos yang efektif. 
Antigen NS1 mempunyai potensi untuk menjadi sasaran diagnostik bagi penyakit 
denggi kerana ia mampu mendorong tindak balas ‘humoral’ yang kuat dan mempunyai 
kepekatan tinggi dalam darah pesakit yang dijangkiti sehingga 9 hari selepas jangkitan 
primer dan sekunder. Walaubagaimanapun, kaedah diagnostik semasa bagi penyakit 
denggi berdasarkan antibodi mengalami beberapa kelemahan. Aptamer, jujukan 
tunggal DNA atau RNA yang mempunyai afiniti dan kekhususan yang tinggi terhadap 
sasaran ialah kelas biomolekul elegan yang berpotensi untuk mengatasi kelemahan 
antibodi. Kajian ini berusaha untuk memperoleh aptamer RNA yang mempunyai 
afiniti dan kekhususan yang tinggi terhadap glikoprotein NS1 virus denggi 2, yang 
merupakan ‘serotype’ yang paling dominan dalam penyakit denggi. Sebanyak 11 
kitaran SELEX telah dijalankan. Pengklonan dan analisa jujukan telah mengenalpasti 
7 kelas jujukan RNA (yang dinamakan seperti DENVI 1 sehingga DENVI 7). DENVI 
1, 3, 4, dan 5 mempunyai penampilan frekuensi yang tinggi dengan peratusan 14%. 
DENVI 2 dan DENVI 6 mempunyai frekuensi sebanyak 7.1% manakala DENVI 7 
xiv 
 
mempunyai frekuensi yang paling kurang sebanyak 3.6%. Analisa ‘nitrocellulose filter 
binding’, menganggarkan nilai penceraian berterusan sebanyak 4.695±1 nM, 16.6±1 
nM dan 6.305±1 nM masing-masing untuk DENVI 3, DENVI 4 and DENVI 6. 
Aptamer RNA yang stabil telah dihasilkan melalui penggabungan 2'-F-dCTP dan 2'-F-
dUTP semasa tindak balas transkripsi in vitro yang mengekalkan penggabungan 
terhadap NS1. ‘In silico molecular docking’ meramalkan struktur tiga dimensi bagi 
kompleks aptamer RNA dan NS1 protein, yang membuktikan penggabungan aptamer 
terhadap protein sasaran. Nukleotida dalam aptamer DENVI 3, DENVI 4 dan DENVI 
6 yang berinteraksi terhadap protein sasaran NS1 juga telah berjaya dikenalpasti, dan 
maklumat ini boleh digunakan untuk pemangkasan atau pengecilan aptamer pada masa 
akan datang. Penyumbang utama kepada interaksi antara aptamers dan protein sasaran, 
NS1 ialah ikatan hidrogen. Aptamer RNA yang dihasilkan mempunyai potensi 
diagnostik terhadap perkembangan pengesanan jangkitan denggi berasaskan aptamer 













GENERATION AND CHARACTERIZATION OF RNA APTAMER AGAINST 





 Dengue Fever, a mosquito borne viral disease, is a malady that plagues tropical 
and subtropical regions. A recent survey by WHO indicated, 3.9 billion of people in 
approximately 128 countries are at risk of infection with dengue viruses. The current 
predicament necessitates an ideal dengue diagnostic test, an assay that is able to 
distinguish dengue fever from other clinically similar diseases, highly sensitive, rapid 
and cost-effective. Antigen NS1 represents the potential diagnostic target of dengue as 
it was found to induce strong humoral response and is present at high concentrations in 
the blood up to 9 days after primary and secondary infections. However, the current 
diagnostic of dengue based on antibodies suffers from several drawbacks. Aptamers, 
ssDNA or RNA that have high affinity and specificity against the target, constitute a 
class of biomolecules that having the potential to alleviate the disadvantages of 
antibodies. This study endeavors to isolate RNA aptamer that have high affinity and 
specificity against NS1 of DENV 2, which is the most common serotype of dengue. A 
total of 11 SELEX cycles were carried out, whereby the eventual nucleic acid pool 
exhibited binding against the target NS1. Sequencing of the RNA pool revealed the 
presence of seven classes of sequences (named DENVI 1 to DENVI 7). DENVI 1, 3, 
4, and 5 have the highest frequency of appearance with the percentage of 14.3%. 
DENVI 2 and DENVI 6 have the frequency of 7.1%, while DENVI 7 has the lowest 
frequency of 3.6%. Nitrocellulose filter binding assay has estimated binding affinity of 
4.69±1 nM, 16.6±1 nM and 6.305±1 nM for DENVI 3, DENVI 4 and DENVI 6 
aptamers, respectively. Stabilized RNA aptamers generated via the incorporation of 2′-
xvi 
 
F-dCTP and 2′-F-dUTP during the in vitro transcription reaction retain binding against 
NS1. In silico molecular docking predicted the three-dimensional structure of the 
aptamer-NS1 protein complex, which corroborates the binding of the aptamers against 
the target protein. Interacting nucleotides of the aptamers DENVI 3, DENVI 4 and 
DENVI 6 against the target protein NS1 were also successfully identified, which could 
be useful for the truncation or miniaturization of the aptamers in future.  The major 
contributor to the interaction between the aptamers and the target NS1 is the hydrogen 
bond. The isolated RNA aptamers harbor diagnostic potential towards the 
development of aptamer-based diagnostic detection of dengue infection and could also 













1.1 Epidemiology of Dengue fever 
 Dengue is a vector-borne or an arthropod-borne viral disease and is an 
important public health issue among tropical and subtropical regions around the 
globe (Nishiura and Halstead, 2007). Dengue fever is an ancient disease (Gubler, 
1997), which bears similarities to the illnesses occurred during the Chin Dynasty 
(AD 265 to 420) (Gubler, 2006; Bhattacharya et al., 2013). Later the breakout was 
reported in three continents such as Asia, Africa and North America between 1779 
and 1780 (Pepper, 1941; Melvyn, 1977). At present, World Health Organization 
have predicted that 40% of world population is at risk of contracting dengue and it 
can cause an immense impact on the global economy (Montibeler and de Oliveira, 
2017). In Malaysia, the first epidemic outbreak was reported in 1973, with 1487 
cases and 54 deaths (Wallace et al., 1980; Mudin, 2015).  Dengue cases remains the 
number one infectious disease with 101,357 cases and 231 deaths reported, though 
the cases reported declined to 71,641 cases in September 2017 (Lokman, 2017). 
 
Dengue is transmitted among human or primates via Aedes aegypti and Aedes 
albopictus in sub-urban and rural areas (Singla et al., 2016), via breeding of the 
mosquitos in domestic water container (Pang et al., 2016). Urban areas constitute 70 
to 80% of reported dengue cases. It has been proven that all gender and ethnic groups 
are equally vulnerable to dengue infection (Pang et al., 2016). Generally, factors that 
account for the occurrences of dengue cases are high density of population, rapid 
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developmental activities or urbanization which favours dengue transmission. In 
Malaysia particularly, rise of dengue cases can be ascribed to climate change such as 
rise of temperature, increased rainfall, higher humidity, rapid industrialization and 
urbanization including improper solid waste disposal account for the rise of dengue 
cases (Mudin, 2015).  
 
1.2 DENV-2 serotype is the most common serotype in Malaysia 
Dengue fever is engendered by Dengue virus (DENV), which is from the 
genus Flavivirus in the family Flaviviridae. Comprising of four distinct phenotypes 
(DEN-1, DEN-2, DEN-3, DEN-4), DENV consists of approximately 11 kb positive 
single-stranded RNA genome, which codes for three structural proteins (Capsid 
protein C, membrane protein M and envelope protein E) and seven non-structural 
proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5). Additionally, a new 
serotype was discovered in 2013 from the serum sample collected during the 2007 
dengue outbreak in Malaysia (Mustafa et al., 2015). The variance among these 
serotypes lies in their genetic makeup (Singla et al., 2016). All serotypes of dengue 
virus are found in Malaysia, but the predominant serotype changes every year. The 
serotypes surveillance showed that dengue cases based on DENV-2 serotype 
increases rapidly starting from March 2013 compared to other serotypes (Mudin, 
2015).  
 
1.3  Current diagnostics of dengue fever  
The current diagnostic of dengue infection is via virus isolation (Tripathi et 
al., 2010) during the period of viraemia (WHO & TDR., 2009). Dengue virus is 
isolated from blood, serum or plasma. The method is expensive and time consuming 
(around 1 to 2 weeks) (WHO & TDR., 2009). Viral RNA detection is also a 
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diagnostic strategy for dengue detection. Serum or blood samples taken from patients 
in the acute phase of disease are subjected to viral RNA isolation and nucleic acid 
amplification test (NAAT) (Peeling et al., 2010). The method can cause false 
positivity due to sample contamination. Dengue is also detected via serological 
methods, whereby immunoglobulins (IgM, IgG, and IgA) specific for the envelope 
protein E are identified via ELISA or direct detection. However, detection of the 
signal varies, depending on whether the patient has primary or secondary infections. 
IgM is detectable 6 to 10 days after the onset of fever, suggesting time as the 
possible limitation of the serological method (Kuno et al., 1991). IgM level is low in 
secondary infections and this could result in false positive results (Hunsperger et al., 
2009). Instead of detecting IgM, direct detection of the antigen of dengue virus is 
viewed as a more feasible strategy of dengue diagnosis as it can be screened as early 
as the first day of infection without perturbation by the presence of IgM (Xu et al., 
2006). 
 
1.4 NS1 protein as the potential diagnostic marker in the direct detection of 
DENV 
 Out of the seven non-structural proteins, antigen non-structural glycoprotein-
1 NS1 is an apposite biomarker for the direct diagnostic detection of the DENV. The 
diagnostic value of NS1 was testified in the diagnostic tests for early infection (Pal et 
al., 2014). NS1 is found to induce strong humoral response and present at high 
concentrations in the blood up to 9 days after primary and secondary infections 
(Peeling et al., 2010). One interesting feature of NS1 is its excretion into the human 
serum after infection. The amount of excreted NS1 in the human serum of an DENV-
2 infected individual was found to be in direct correlation with viremia (Libraty et 
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al., 2002). Another added advantage of using NS1 protein is that the presence of anti-
dengue immunoglobulin M (IgM) antibodies do not hinder its detection (Xu et al., 
2006). 
 
1.5 Antibody-based detection of NS1 protein suffers from several drawbacks 
Several direct detection test kits were developed based on DENV-2 NS1 such 
as Panbio test, InBios test, and Bio-Rad test which are antibody-based assays. The 
sensitivities scored were 94.1%, 100.0%, and 80.0% for Panbio test, InBios test and 
Bio-Rad test, respectively (Pal et al., 2014).  
 
Though high sensitivity was scored for these antibody-based assays, 
antibodies as the diagnostic agent have several disadvantages.  These include high 
cost associated with antibodies and non-specific binding of antibodies that may cause 
false-positive results. One amenable class of Molecular recognition element (MRE) 
that harbours the capacity to address the shortcomings of antibodies are aptamers.  
 
1.6 Aptamers 
 Aptamers are ssDNAs or RNAs that comprise of a myriad of secondary and 
tertiary structures which promotes binding to a wide variety of targets with high 
specificity. The word ‘aptamer’ is derived from the term ‘aptus’ which means to fit 
in Latin (Ellington & Szostak., 1990) and the term ‘meros’ which refers to particle in 
Greek (Stoltenburg et al., 2007). 
 
Aptamers are the output of an in vitro selection process, widely known as 
Systematic Evolution of Ligands by Exponential Enrichment. Systematic Evolution 
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of Ligands by Exponential Enrichment (SELEX) consists of 3 major steps of; (i) 
incubation of the randomized oligonucleotide library with the target; (ii) separation 
of the bound from unbound nucleic acid ligands; and (iii) amplification (Stoltenburg 
et al., 2007). 
 
1.7 Advantages of aptamers over antibodies 
 Unlike antibodies, aptamers are easier to be modified and exhibits no batch-
to-batch variations. Moreover, aptamers have high discerning features, able to 
discriminate very similarly structured biomolecules such as between caffeine and 
theophyline (Jenison et al., 1994). Aptamers are able to be selected against a wide 
range of targets such as ions, drugs, toxins, peptides, proteins, viruses, bacteria, cells, 
and even tissues (Parekh et al., 2010; Bayrac et al., 2011). The smaller size of 
aptamers (probably 8-25 kDa compared to ~150 kDa of antibodies) permits faster 
and more efficient tissue penetration (Sun et al., 2014). Aptamers are less 
immunogenic compared to antibodies (Eyetech study group, 2002; Eyetech study 
group, 2003). Aptamers have reversibly denaturation property. Aptamers can be 
synthesised with much more lower cost compared to that of antibodies.  
 
1.8 Aptamer-based diagnostics (Aptanostics) 
Aptamers have excellent features that qualify them as an ideal class of 
diagnostic agent. Aptamer isolated against Ochratoxin A (OTA), a nephrotoxic and 
teratogenic   secondary metabolite generated by Aspergillus and Penicillium strains, 
was used in the Enzyme-Linked Aptamer Assay (ELAA). The detection limit 
achieved was 1 ng/mL. Aptamer isolated against Aflatoxin B1 was also used in the 
fluorescent-based aptamer assay for the detection of the metabolite in food samples 
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(Malhotra et al., 2014). A DNA aptamer isolated against inactivated intact H1N1 
virus particles was applied in sandwich enzyme-linked oligonucleotide assay 
(ELONA) and in an electrochemical impedance (EIS) aptasensor. The detection limit 
was 0.3 ng/µL in ELONA and 0.9 pg/µL in EIS, respectively (Bai et al., 2018).  
 
1.9 Problem statement 
The disadvantages associated with antibodies evoke an effort to shift from the 
antibody-centric diagnostic to aptamer-based diagnostic of NS1 protein. Isolation 
and characterization of aptamer against NS1 are envisaged to assuage the drawbacks 
associated with antibodies and could effectively pave the path towards the 
aptasensing of NS1 for dengue detection.  
 
1.10 Objectives 
The purpose of this study is to isolate RNA aptamers against NS1 protein and to 
further characterize the isolated aptamers. 
1) To generate RNA aptamers that have high sensitivity and specificity for DENV-
2 NS1. 
i. Execution of SELEX cycles up to cycle 11. 
ii. Interrogation of binding of the nucleic acid pool from cycle 5, 8 and 11 
against NS1. 
iii. Cloning, sequencing and bioinformatics analysis of the potential RNA 
aptamer candidates. 
2) To characterize the generated RNA aptamers. 
i. Determination of the dissociation constant of the selected RNA aptamers. 




iii. Determination of the secondary structures of the selected aptamers. 
3) To simulate the aptamer-NS1 protein complex formation by in silico prediction.   
i. To perform a rigid docking between the aptamers and the NS1 protein by 
PatchDock. 











IN VITRO SELECTION AGAINST NS1 PROTEIN 
 
2.1 Introduction 
 In vitro process or also known as Systematic Evolution of Ligands by 
Exponential Enrichment (SELEX) is a technique used to isolate aptamers against 





single stranded nucleic acids are incubated with the target of interest. Following 
incubation, the target-bound sequences are separated from the unbound sequences 
via a process known as partitioning. The sequence bound molecules are eluted and 
subjected to amplification. At this juncture, the resulting double-stranded DNA 
sequences were converted to single-stranded sequences in the case of DNA aptamer 
generation (Marimuthu et al., 2012). For RNA aptamer generation, double-stranded 
DNA sequences were used as the templates for the production of RNA via in vitro 
transcription (Gopinath, 2011). The resulting molecules were used for the next round 
of SELEX and this process was repeated for 8-11 rounds. At the end of the SELEX 
cycles, PCR product was cloned and subjected to sequencing. Sequence analysis 
reveals the potential aptamers based on the frequency of appearance (Figure 2.1).  
In this study, SELEX will be carried out against the target NS1 protein. After 
certain cycles of SELEX, the binding of the nucleic acid pool against the target NS1 
will be interrogated. Having affirmed the binding of the nucleic acid pool against the 
target protein, sequencing and analysis of the sequences were carried out to identify 































2.2 Materials and Methods 
2.2.1 Designing random ssDNA library and primers 
 Random ssDNA library and the primers were purchased from Integrated 
DNA Technology (IDT, Iowa, USA). In this study, the random ssDNA library was 
designed with the length of 118 nucleotides, comprising of primer binding regions 
that flank the randomized region in the middle. The primer binding regions having 
the length of 19 nucleotides and 20 nucleotides bind to both the forward and reverse 
primers, respectively. The forward primer binding region has the T7 promoter 
sequence. The randomized region was designed with a length of 60 nucleotides, 
which theoretically accounts for 4
60 
of different sequences. The random ssDNA 




 N60 represents the randomized region of the ssDNA library, while the 
underlined region is the T7 promoter sequence. ‘N’ can be either A, C, G, and T. For 
the production of RNA molecules, the random ssDNA molecules are first PCR-
amplified followed by in vitro transcription.  
 
2.2.2 PCR amplification 
 PCR amplification was carried out in a 100 μL reaction mixture containing 
0.2 mM dNTPs (Promega, Madison, WI USA), 1 X PCR buffer (Yeastern Biotech 
Co., Taipei, Taiwan), 2 µM forward, 2 µM reverse primer and 5 U YEAtaq DNA 
Polymerase (Yeastern Biotech Co., Taipei, Taiwan). PCR amplification was 
executed using Biorad MyCyler Thermal Cycler and the parameters for PCR cycles 
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were as follow: an initial denaturation at 95°C for 60 s, amplification cycles that 
consist of 30 s denaturation at 95°C, 30 s annealing at 55°C, 30 s extension at 72°C 
and final elongation of 120 s at 72°C. The amplification was carried out starting at 
PCR cycle 6 and additional cycles were added till the PCR band with the correct size 
appears in each SELEX cycle. 
 
2.2.3 Gel electrophoresis 
For the visualization of the PCR product, 5 µL of the PCR product was mixed 
with 1 μL of 6X Bromophenol DNA loading dye (10 mM Tris-HCl [pH 7.5], 50 mM 
EDTA [pH 8.0], 0.03% bromophenol blue). This mixture was added with ethidium 
bromide, EtBr to a final concentration of 0.5 μg/mL (Sigma, St. Louis, USA). The 
mixture was loaded onto 4% agarose gel (Promega Corporation, Madison, USA) and 
the electrophoresis was run using an agarose mini gel apparatus (Bio-Rad 
Laboratories, Hercules, USA) in 1 X TAE buffer (40 mM Tris-acetate, 1 mM EDTA) 
at 100 V for 30 minutes. The gel was visualized with Gel Doc™ XR+ Gel 
documentation system (BioRad, California, USA). The PCR amplicon size with the 
expected size of 118 bp was confirmed with 25 bp DNA ladder (Promega 
Corporation, Madison, USA).   
 
2.2.4 Ethanol precipitation 
The PCR products were subjected to ethanol precipitation. One mL of 
absolute ethanol (Merck KGaA, Darmstadt, Germany), 40 µL of 3 M Sodium acetate 
(NaOAc) pH 5.2 (R & M Marketing, Essex, U.K.) and 300 µL ddH2O were added 
together with the PCR product. The mixture was incubated for 30 minutes at -80°C. 
Subsequently, the mixture was centrifuged at 24,000 x g for 15 minutes at 4°C using 
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Sorvall™ ST 16R centrifuge (Thermo Fisher Scientific, Massachusetts, USA) and 
the supernatant was discarded. The resulting pellet was washed with 70% ethanol 
solution and air-dried in a vacuum concentrator (Eppendorf, Hamburg, Germany) for 
5 minutes. Finally, the pellet was resuspended in 8 µL of ddH2O. 
 
2.2.5 In-vitro transcription 
 Four microliters of the ethanol precipitated PCR product was used as the 
template for an in vitro transcription reaction. In-vitro transcription was carried out 
using Ampliscribe™ T7-Flash™ Transcription kit (Epicentre, Wisconsin, USA). The 
In vitro transcription reaction mixture was assembled in a 20 μL reaction mixture 
containing 1 X AmpliScribe T7 reaction buffer (40 mM Tris-HCl [pH 7.5], 6 mM 
MgCl2, 10 mM NaCl, 2 mM spermidine), 7.5 mM each of ATP, CTP, UTP, GTP, 10 
mM of dithiothreitol (DTT), 20 U of AmpliScribeTM T7 Polymerase Flash Enzyme 
Solution (10 U/μL) and 20 U of RiboGuard RNase Inhibitor (40 U/μL). The mixture 
was then incubated at 37°C for 16 hours in a water bath (Fisher Scientific 
International, Inc., Hampton, USA).  Followed by the incubation, treatment with 10 
U of RNase-Free DNase I (Fermentas, Burlington, Canada) was done for 20 minutes 
at 37°C. The in vitro transcription reaction was stopped by adding equal volume of 2 
X RNA loading dye (8 M urea, 0.05% bromophenol blue) and the mixture was 
heated at 95°C for 2 min in a thermomixer (Eppendorf, Hamburg, Germany). 
 
2.2.6  Denaturing Urea PAGE 
 The in vitro transcription reaction was loaded onto 12%, 7 M denaturing-urea 
polyacrylamide gel in 1 X TBE (89 mM Tris-borate [pH 8.0], 2 mM EDTA) and 
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electrophoresed using BioRad Mini-PROTEAN 3 Electrophoresis Cell (Bio-Rad 
Laboratories, Hercules, USA) at 140 V for 1 hr.  
 
2.2.7 Purification of transcribed RNA 
 After the completion of the electrophoresis, the gel was covered with a plastic 
wrap and was placed on top of the silica coated glass plate (Merck KGaA, 
Darmstadt, Germany). The band of interest was visualized by using a hand-held u.v. 
light source (UVP, LLC, Upland, USA). Band of interest which appears as a single 
prominent band under low-intensity u.v. shadowing (254 nm) was excised and 
transferred into a sterile 1.5 mL microcentrifuge tube (Eppendorf, Hamburg, 
Germany). The gel slices were meshed by using 1 mL pipette tip. The crushed gel 
particles were added with 400 μL of ddH2O and heated at 60°C for 60 min to liberate 
the RNA that are ‘incarcerated’ in the gel matrix. One mL of absolute ethanol was 
added into the mixture and mixed vigorously. The mixture was centrifuged at 24,000 
x g for 2 min at 4°C, followed by the collection of the supernatant into a fresh 
microcentrifuge tube and was added with 40 µL of 3 M Sodium acetate, NaOAc (pH 
5.2). The solution was mixed and incubated at -80°C for 30 min followed by 
centrifugation at 24,000 x g for 15 min at 4°C. The supernatant was removed and the 
pellet was washed with 1 mL of 70% ethanol. Following a brief centrifugation at 
24,000 x g for 2 min, supernatant was removed, the pellet was air-dried and 
dissolved in 25 µL of ddH2O. The concentration of the RNA was estimated using 







 The prepared RNA pool was subjected to SELEX cycles comprising of an 
iterative process of incubation, partitioning, elution and amplification. The sequences 
were identified by cloning and sequence analysis.   
 
2.2.8(a) RNA pool-target protein complex formation 
 A reaction mixture that comprises of 6.25 µM of initial RNA pool, and 1 X 
SELEX binding buffer (150 mM NaCl and 10 mM HEPES-KOH [pH 7.4]) (GE 
Healthcare Bio Sciences, Uppsala, Sweden) was prepared. The mixture was heated 
up to 2 minutes at 95°C followed by cooling at RT for 10 minutes. The mixture was 
then added with 10.2 µM yeast tRNA (Invitrogen Corporation, Carlsbad, USA) as 
competitor followed by the addition of 2.5 µM of Dengue virus 2 NS1 glycoprotein 
(Abcam, Thailand). The reaction mixture was incubated at RT for 15 minutes. The 
concentration of RNA pool, yeast tRNA, and NS1 glycoprotein used in every 
SELEX cycle is varied. 
 
2.2.8(b) Nitrocellulose filter membrane and microtiter-based partitioning 
 Nitrocellulose filter membrane was used for partitioning in SELEX cycle 1, 
2, 4, 6, 7, 9, and 10. Nitrocellulose filter membrane (0.45 µm) was placed on top of 
the pop top filter and pre-wetted with 1 X SELEX buffer. The resulted mixture (from 
section 2.2.8(a)), was pipetted on top of the membrane filter and with the aid of the 
vacuum suction the unbound RNA molecules were removed. One mL of 1 X SELEX 
buffer was used to wash the membrane and the membrane was collected and placed 




 Partitioning for SELEX cycles 3, 5, 8, and 11 were aided by Xenobind plate 
(Xenopore, Hawthorne, NJ). First, the wells were washed with 1 X SELEX buffer 
for once to remove contaminants. Initially, the wells were coated with 1.5 µM of 
Dengue 2 Virus NS1 glycoprotein in 50 mM sodium phosphate buffer (pH 7.5) and 
incubated overnight at RT. After incubation, the wells were washed with 300 µL of 
0.05% PBST for 3 times to remove the unbound proteins from the wells, followed by 
coating of the wells with 3% BSA for 3 hours at RT. Two other empty wells were 
also coated with 3% BSA for SELEX pre-selection step under the same condition 
before washing thrice to remove unbound BSA.  
 
For the selection on the microtiter plate, RNA mixture heated at 95ºC for 2 
min and cooled at RT for 10 min was incubated in the 3% BSA coated wells for pre-
selection at RT for 8 min. The unbound RNA sequences, which in the form of 
supernatant was collected from the 3% BSA coated wells added with yeast tRNA. 
The reaction mixture was added into the NS1 protein-coated wells and incubated at 
RT for 15 min. The wells were washed with 0.05% PBST for 3 times before elution. 
 
2.2.8(c) Elution of target-bound nucleic acid 
The RNAs were recovered from the filter membrane by heating at 95°C with 
400 µL of 7 M urea for 2 min. Similarly, the bound RNAs on the surface of the wells 
were recovered using boiled 7 M urea. The eluted RNAs were subjected to ethanol 






2.2.8(d) Reverse transcription of eluted RNA molecules 
 The eluted RNA molecules were subjected to reverse transcription reaction. 
The reaction mixture was prepared to contain 1 X Revert AID reverse transcriptase 
reaction buffer (50 mM Tris-HCl [pH 8.5], 8 mM MgCl2, 30 mM KCl, 1 mM DTT) 
(Thermo Fisher Scientific, Massachusetts, USA), 0.4 µM of reverse primer and 
ddH2O. The ethanol precipitated RNAs were resuspended in the reverse transcription 
reaction mixture. The mixture was heated for 2 min at 95ºC followed by cooling to 
RT for 10 min. To the reaction mixture, 1.6 mM dNTPs and 10 U of RevertAID 
reverse transcriptase (Thermo Fisher Scientific, Massachusetts, USA) were added 
and was incubated at 60ºC for 1 hour. The resulting cDNA from the reverse 
transcription reaction mixture was PCR amplified, ethanol precipitated and used for 
in vitro transcription to prepare RNA molecules for the next round of SELEX. 
 
2.2.8(e) Counter-selection against nitrocellulose filter membrane/prefiltration 
 This step is vital to minimize sequences that bind to the nitrocellulose filter 
membrane prior to each SELEX cycle. The step was carried out at each SELEX 
cycle. The purified RNA was added with 400 µL of 1 X HEPES buffer and the 
mixture was heated at 95ºC for 2 min. The solution was left at RT for 10 min to 
equilibrate to RT. Then, the RNA was gradually passed through a nitrocellulose filter 
membrane placed inside the pop top filter holder using a 1 mL syringe. Prefiltration 
was carried out thrice and the filtered RNA solution was ethanol precipitated before 






2.2.8(f) 5’- end labeling of the RNA pool with (γ-32P) ATP 
 Prior to the labelling of the RNA at the 5’-end with (γ-32P) ATP, 
dephosphorylation was carried out. The dephosphorylation mixture consists of 1 X 
alkaline phosphatase buffer (New England Biolabs, Massachusetts, USA), 0.26 µM 
of RNA and 5 U/µL of alkaline phosphatase enzyme (New England Biolabs, 
Massachusetts, USA). The reaction mixture was incubated at 37°C for 60 min before 
ethanol precipitation with Dr.GenTLE
TM 
precipitation carrier.  
 
 The dephosphorylated RNA was added to a reaction mixture containing 1 X 
T4 RNA ligase reaction buffer A (Thermo Fisher Scientific, Massachusetts, USA), 
6.6 pmol of radiolabeled γ32P-ATP (Perkin Elmer, Massachusets, USA) and 10 U of 
T4 ploynucleotide kinase, PNK (Promega, Wisconsin, USA). The mixture was 
incubated at 37°C for 60 min in a waterbath. The radiolabelled RNA was purified 
using Quick spin radiolabeled RNA purification Sphadex G-25 column (Roche 
Diagnostics GmbH, Mannheim, Germany). 
 
2.2.8(g) Nitrocellulose filter binding assay for assessing the binding of the RNA 
pools against NS1 protein 
 Nitrocellulose filter binding assay was carried out as reported previously 
(Yamamoto et al., 2000; Kumarevel et al., 2004a; Kumarevel et al., 2004b). The final 
concentration of 1 nM of radiolabeled RNA pool sequences in reaction mixture that 
contained 1 X binding buffer and ddH2O, were heated at 95°C for 2 min followed by 
cooling at RT for 10 min.  The RNA reaction mixture was added with 200 nM of 
yeast tRNA and various concentrations of NS1 glycoprotein that were prepared in 
the reaction volume of 50 µL were added and incubated for 15 min at RT. 
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 cycle of SELEX were 0, 800, 
and 1600 nM, respectively. The reaction mixtures were filtered through pre-wet 
nitrocellulose filter membranes under vacuum suction and were washed with 1 mL of 
1 X HEPES buffer. Following the filtration and washing, the filter membranes were 
collected and exposed to X-ray film before imaging using auto-radiography.  
 
 After the completion of SELEX cycles, PCR product was subjected to 
cloning and transformation. The plasmids were extracted and sequenced. The 
sequences obtained were arranged into clusters and their binding against NS1 protein 
was assessed. 
 
2 .2 .9  Cloning and sequencing 
2.2.9(a) Cloning and transformation 
 RNA pool after the completion of SELEX cycles were subjected to PCR 
amplification with the extension time extended up to 10 min. The resulting PCR 
product was cloned into pCR@2.1 cloning vector using TOPO TA cloning kit 
(Thermo Fisher Scientific, Massachusetts, USA). The reaction mixture for cloning 
was set up such that it contains 2 µL of PCR product, 1 µL of salt solution (1.2 M 
NaCl and 0.06 M MgCl2), 2 µL ddH2O, and 1 µL pCR@2.1 cloning vector. The 
mixture was incubated for 30 min at RT.  
 
 Chemically competent Escherichia coli (TOP 10 strain) cell was thawed on 
ice for a few min. The prepared ligation mixture was added into the thawed cells and 
the mixture was incubated on ice for 15 min. The plasmids and cells mixture were 
subjected to a heat shock state in a 42ºC water-bath for 45 seconds and 800 µL of LB 
19 
 
broth was added into the mixture immediately afterwards. Later, the mixture was 
incubated at 37ºC with shaking for 90 min. Meanwhile, a mixture of 50 µL of 100 
mM IPTG (Fermentas, Burlington, Canada), 50 µL of 40 mg/mL X-Gal (Takara Bio, 
Shiga, Japan), and 25 µL of LB broth were spread on top of LB agar plate 
(Pronadisa, Madrid, Spain) containing 50 µg/mL kanamycin (Roche Daignoctics 
GmbH, Mannheim, Germany). Following the completion of the incubation at 37ºC, 
the cell suspension was spread on the surface of the LB agar plate. The plate was 
incubated overnight at 37ºC.  
 
2.2.9(b) Plasmid extraction   
 A total of 30 white colonies (denotes the presence of cloned sequences) were 
randomly picked from the LB-kanamycin plate and inoculated into 10 mL LB broth 
containing 50 µg/mL kanamycin. The inoculation was incubated for overnight at 
37°C with shaking. Later, plasmid extraction was done using High Pure Plasmid 
Isolation Kit (Roche Daignostics GmbH, Mannheim, Germany). The steps were 
according to the manufacturer’s instructions with few modifications. One mL of 
overnight culture was aliquoted in 1.5 mL microcentrifuge tube and was centrifuged 
at 6,000 x g for 1 min. The tubes were added with 250 µL of suspension 
buffer/RNase (50 mM Tris-HCl and 10 mM EDTA, pH 8.0) the pellets were 
resuspended before the addition of 250 µL of lysis buffer (0.2 M NaOH and 1% 
SDS). The tubes were inverted few times slowly to mix the mixture slowly and were 
incubated at RT for 5 min. Afterwards, chilled 350 µL binding buffer (4 M guanidine 
hydrochloride and 0.5 M potassium acetate, pH 4.2) was added to the tubes and the 
tubes were inverted few times slowly and incubated on ice for 5 min until the 
flocculant can be seen. The mixture was centrifuged for 10 min at maximum speed 
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of 13,000 x g at 4°C. The resulted supernatant was transferred into high pure filter 
tubes housed in a microcentrifuge tubes and was centrifuged at 13,000 x g for 1 min. 
Flow-through from the collection tube was discarded and 500 µL of washing buffer I 
(5 M guanidine hydrochloride, and 20 mM tris-HCl, pH 6.6) were added into the 
high pure filter tubes and was centrifuged under the same conditions as before. The 
resulted flow-through was discarded before 700 µL of washing buffer II (20 mM 
NaCl, 2 mM tris-HCl, pH 7.5) were added and centrifuged as before. The flow-
through was decanted and the previous step was repeated one more time without the 
addition of washing buffer. The high pure filter tube was later transferred to new 
sterile 1.5 mL microcentrifuge tubes and 30 µL of elution buffer (10 mM tris-HCl, 
pH 8.5) was added into the filter tubes before it was centrifuged for 1 min at 13,000 
x g. The extracted plasmid concentrations were quantified using nanodrop and stored 
in -20°C prior to use.         
 
2.2.9(c) DNA sequencing  
 The quality of plasmids was confirmed by 0.8% agarose gel electrophoresis. 
The plasmid (0.5 µg) was mixed with 20 pmol of M13 forward primer and 
sequencing was carried out by First BASE Laboratories Sdn. Bhd., Selangor, 
Malaysia.                   
 
2.2.9(d) Sequence analysis 
 The sequences obtained were analyzed for sequence homology using 
CLUSTALW (http://www.ebi.ac.uk/clustalw/). Similar sequences were clustered 
together and the frequency of appearance will be calculated. The most abundant 
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sequence clusters were subjected to binding evaluation against the target NS1 
protein.       
2.3  Results and Discussion 
2.3 .1  Eleven cycles of SELEX were successfully completed 
 The selection buffer used in this study was 10 mM HEPES buffer which 
contained 150 mM of NaCl (Carothers et al., 2010). The monovalent ion Na
+
 
functions to ‘appease’ the electrostatic repulsion between the negatively charged 
nucleic acids and the negatively charged target molecule. HEPES functions as the 
buffering agent to resists pH change.  
 
In this study, a total of 11 cycles of SELEX were carried out. The parameters 
such as RNA pool concentration, target protein concentration and competitor yeast 
tRNA concentration that were used in this study are shown in Table 2.1. Throughout 
the SELEX process, selection pressure was exerted by reducing the amount of target 




Table 2.1: The parameters used for eleven SELEX cycles. Nitrocellulose filter membrane-based partitioning 
was used for all the SELEX cycles except for the cycles with the notations ‘*’, in which Xenobind plate-


























1 6.6 10.2 2.5 8 
2 3.9 30.6 2.0 8 
3* 2.1 50.9 1.5 8 
4 1.6 81.6 1.0 8 
5* 1.1 112.2 0.75 8 
6 0.8 152.9 0.5 8 
7 0.4 193.7 0.25 6 
8* 0.3 203.9 0.125 6 
9 0.3 203.9 0.125 6 
10 0.2 203.9 0.1 5 






2.3.2  Nitrocellulose filter membrane-based partitioning as the simple and 
rapid approach 
 Nitrocellulose filter membrane is used extensively as it offers a simple and 
rapid retention of protein by its non-specific affinity against amino acids (Song et al., 
2012). Moreover, nitrocellulose membrane does not require the immobilization of 
target proteins as is necessitated by other revenues such as affinity chromatography, 
magnetic beads and capillary electrophoresis. The principle of partitioning is based 
on the retention of the target protein on the surface of nitrocellulose filter membrane, 
which also retains nucleic acid molecules that have affinity against the protein. By 
means of vacuum suction, nucleic acid molecules that do not interact with the protein 
are discarded. Subsequently, the membrane was treated with 7 M urea. Urea, as a 
strong chaotropic agent denatures protein, releasing the protein-bound RNA 
molecules.  
 
2 .3 .3  Nature of the PCR amplification in SELEX  
The eluted RNA molecules were converted to first-strand cDNAs followed 
by PCR amplification. In each SELEX cycle, the band with the expected size of 118 
bp was obtained (Figure 2.2). As the template being amplified is short, no 
optimization of annealing temperature for PCR amplification was needed. Standard 
MgCl2 concentration of 1.5 mM and 0.2 mM concentration of dNTPs were used for 
the PCR amplification. Taq Polymerase was used for the enzymatic amplification 
despite lacking 3'-5' exonuclease proof-reading. Mutation resulting from the absence 
of this proof-reading activity was viewed as an added advantage in creating the 
diversity of the nucleic acid pool (Bartlett and Stirling, 2003).  
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PCR amplification for the template amplification is very crucial and sensitive 
step. A highly efficient amplification is needed to minimize the amplification bias 
and to reduce the loss of potential high affinity binders at early stages of SELEX 
cycle. This is also pivotal to suppress the fecundity of non-target binders. One of the 
most important circumspection practised throughout the SELEX process is to 
minimize the number of PCR cycles. The PCR cycles were added in the increments 
of 1 or 2 PCR cycles starting from PCR cycle 6 until the band of the expected size 
appears. The PCR cycles for each SELEX cycle were maintained as low as possible 
to diminish the accumulation of unintended or ‘cryptic’ PCR products. Over 
amplification could permit the DNA templates having randomized region in the 
middle to form Watson Crick base-pairing with each other. This phenomenon is 
known as opportunistic mispairing and is accountable for the appearance of aberrant 
or cryptic PCR products, which could oppress the amplification of intended target 




























Figure 2.2: A representative of the gel electrophoresis of the PCR product from 
SELEX cycle 2. Eight cycles of PCR were carried out using the reverse-transcribed 
RNA pool from SELEX cycle 2 as the template. The product was electrophoresed on 















118 bp RT-PCR 
product. 
1 2 
125 bp 
100 bp 
